Calidi Biotherapeutics (CLDI) News Today → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free CLDI Stock Alerts $0.20 0.00 (-1.99%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCalidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meetingbusinesswire.com - May 1 at 7:00 AMJoin Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24finance.yahoo.com - April 23 at 7:33 AMJoin Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24businesswire.com - April 23 at 7:00 AMCalidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offeringbusinesswire.com - April 19 at 4:05 PMWhy Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%msn.com - April 16 at 3:13 PMWhy Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?investorplace.com - April 16 at 9:11 AMCalidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offeringbusinesswire.com - April 16 at 8:31 AMCalidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024finance.yahoo.com - April 9 at 9:31 AMCalidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024businesswire.com - April 9 at 7:00 AMCLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023investorplace.com - March 16 at 12:07 AMCalidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Resultsbusinesswire.com - March 15 at 4:05 PMCalidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancerbusinesswire.com - March 11 at 7:00 AMCalidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conferencefinance.yahoo.com - February 12 at 9:56 AMCalidi Biotherapeutics Shares Informal Financial Updatemsn.com - February 8 at 3:22 PMCalidi Biotherapeutics Conducts Private Equity Salemsn.com - February 2 at 2:56 PMCalidi Biotherapeutics, Inc. (CLDI)uk.finance.yahoo.com - January 9 at 7:52 AMCalidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Boardfinance.yahoo.com - January 8 at 10:34 AMCalidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directorsfinance.yahoo.com - December 12 at 11:29 AMCalidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023finance.yahoo.com - December 5 at 10:09 AMCalidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officerfinance.yahoo.com - December 5 at 10:09 AMCalidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointmentfinance.yahoo.com - December 5 at 10:09 AMCalidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)finance.yahoo.com - December 5 at 10:09 AMCalidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Resultsfinance.yahoo.com - December 5 at 10:09 AMCalidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestonesfinance.yahoo.com - December 5 at 10:09 AM Get Calidi Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CLDI and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. CLDI Media Mentions By Week CLDI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLDI News Sentiment▼0.000.42▲Average Medical News Sentiment CLDI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLDI Articles This Week▼11▲CLDI Articles Average Week Get Calidi Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CLDI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Creative Medical Technology News Fresh Tracks Therapeutics News Palisade Bio News Titan Pharmaceuticals News TRACON Pharmaceuticals News Kiromic BioPharma News Sorrento Therapeutics News Finch Therapeutics Group News Avalon GloboCare News Genetic Technologies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:CLDI) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
